A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia
- PMID: 2284152
- DOI: 10.1203/00006450-199012000-00004
A recycling defect as a characteristic of natural killer cells in childhood acute lymphoblastic leukemia
Abstract
The cytolytic function of natural killer (NK) cells and their responsiveness to interferon-alpha and IL-2 were investigated in children with acute lymphoblastic leukemia (ALL) using 51Cr-release and single-cell assays. For comparison, such NK cell functions were similarly assayed in neuroblastoma. NK activity in ALL children was extremely low at onset, but it increased gradually during remission and finally reached normal levels. At the single-cell level, their NK cells at onset were defective in the binding, lytic, and recycling abilities. Although the binding and lytic defects improved to normal levels during remission, the recycling, which increased gradually during remission, was still low even after the long-term remission in ALL: the maximal recycling capacity values were 1.9 +/- 0.4 (p less than 0.001) at onset and 4.6 +/- 0.6 (p less than 0.05) after 5 y of complete remission, as compared to the value in control children of 5.4 +/- 0.7. On the other hand, children with neuroblastoma had no recycling defect after completing the therapy: their maximal recycling capacity value was 5.6 +/- 0.7. Bone marrow cells in ALL were also depressed in their recycling ability at all stages. Interferon-alpha and IL-2 could enhance NK activity and IL-2 could generate lymphokine-activated killer activity at all stages of ALL; however, the recycling defect hardly improved with these treatments. Thus, NK cells in childhood ALL have a recycling defect as a functional characteristic.
Similar articles
-
Absence of responsiveness to interferon-gamma but not to interleukin 2 and depressed recycling as natural killer cell abnormalities in childhood lymphohistiocytic syndrome.Int J Hematol. 1994 Jun;59(4):273-80. Int J Hematol. 1994. PMID: 8086621
-
Development of natural killer cytotoxicity during childhood: marked increases in number of natural killer cells with adequate cytotoxic abilities during infancy to early childhood.Pediatr Res. 1990 Oct;28(4):316-22. doi: 10.1203/00006450-199010000-00002. Pediatr Res. 1990. PMID: 1700360
-
Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.J Immunol. 1989 Nov 15;143(10):3241-9. J Immunol. 1989. PMID: 2809200
-
Natural killer activity of pediatric patients with acute lymphoblastic leukemia in remission.Jpn J Clin Oncol. 1984 Sep;14(3):335-45. Jpn J Clin Oncol. 1984. PMID: 6592376
-
Increased natural killer cell activity and numbers of Leu-7 and Leu-11b (CD 16)-positive cells in bone marrow of children in remission from acute lymphoblastic leukaemia.Scand J Immunol. 1989 Jan;29(1):65-72. doi: 10.1111/j.1365-3083.1989.tb01100.x. Scand J Immunol. 1989. PMID: 2466327
Cited by
-
Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-alpha 2a and interleukin-2.Cancer Immunol Immunother. 1992;35(6):401-11. doi: 10.1007/BF01789019. Cancer Immunol Immunother. 1992. PMID: 1394343 Free PMC article. Clinical Trial.
-
Late immune recovery in children treated for malignant diseases.Pathol Oncol Res. 2008 Dec;14(4):391-7. doi: 10.1007/s12253-008-9073-5. Epub 2008 Jun 25. Pathol Oncol Res. 2008. PMID: 18575827
MeSH terms
Substances
LinkOut - more resources
Full Text Sources